poisar

Stock

MaxCyte, Inc. MXCT

$1.45+14.17%

Overview

MXCT market data

Price History

MXCT price chart

Valuation & Profitability

Provider-backed
P/E (TTM)
Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
Forward P/E
P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
EPS (TTM)
-$0.42
Diluted earnings per share over the trailing twelve months.
Beta
1.48
Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
Dividend Yield
Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
Profit Margin
-121.2%
Net income divided by revenue. Comparable within a sector, less so across sectors.
52w range
$0.64 – $1.87
Lowest and highest closing prices over the past 52 weeks.
Analyst Target
Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.

Display-only. Refreshed once per symbol per 24 hours · market cap $128M · P/B 0.96 · P/S 3.96.

Company News

4 captured
8-K filing — MAXCYTE, INC. (MXCT)SEC EDGAR · Aug 12, 2026, 8:14 PM
MaxCyte Affirms FY2026 Sales Guidance of $30.000M-$32.000M vs $31.082M EstBenzinga · Aug 12, 2026, 8:09 PM
MaxCyte Q2 EPS $(0.08) Beats $(0.09) Estimate, Sales $7.271M Beat $6.475M EstimateBenzinga · Aug 12, 2026, 8:09 PM
MaxCyte Enters Into Technology License Partnership With Genentech To Support Development Of Cell Therapy ProgramsBenzinga · Jul 21, 2026, 12:06 PM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock